Stock Report

Vivanza Biosciences Ltd consolidated Q4 FY2022-23 loss at Rs. 10.36 lakhs



Posted On : 2023-04-25 19:33:51( TIMEZONE : IST )

Vivanza Biosciences Ltd consolidated Q4 FY2022-23 loss at Rs. 10.36 lakhs

has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 8.3627 crores during the period ended March 31, 2023 as compared to Rs. 5.8707 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. -0.1036 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.4584 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. -0.26 for the period ended March 31, 2023 as compared to Rs. 1.15 for the period ended December 31, 2022.

Financials Q4 FY2023 Q3 FY2023 % Change
Total Income ₹8.3627 crs ₹5.8707 crs Up Tick / Down Tick42.45%
Net Profit ₹-0.1036 crs ₹0.4584 crs Up Tick / Down Tick-122.60%
EPS ₹-0.26 ₹1.15 Up Tick / Down Tick-122.61%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.8.3627 crores during the period ended March 31, 2023 as compared to Rs.6.14 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.-0.1036 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-0.20 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.-0.26 for the period ended March 31, 2023 as compared to Rs.-0.50 for the period ended March 31, 2022.

Financials Q4 FY2023 Q4 FY2022 % Change
Total Income ₹8.3627 crs ₹6.14 crs Up Tick / Down Tick36.20%
Net Profit ₹-0.1036 crs ₹-0.20 crs Up Tick / Down Tick48.20%
EPS ₹-0.26 ₹-0.50 Up Tick / Down Tick48.00%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.18.2824 crores during the Financial Year ended March 31, 2023 as compared to Rs.11.2290 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.0.5983 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.0.3330 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.1.50 for the Financial Year ended March 31, 2023 as compared to Rs.0.83 for the Financial Year ended March 31, 2022.

Financials Year Ended FY2023 Year Ended FY2022 % Change
Total Income ₹18.2824 crs ₹11.2290 crs Up Tick / Down Tick62.81%
Net Profit ₹0.5983 crs ₹0.3330 crs Up Tick / Down Tick79.67%
EPS ₹1.50 ₹0.83 Up Tick / Down Tick80.72%

Source : Equity Bulls

Keywords

VivanzaBiosciences Q4FY23 FY2023 ResultUpdate